Artificial Intelligence in Medical Affairs: A New Paradigm with Novel Opportunities-Reference-Cited by-同舟云学术

Artificial Intelligence in Medical Affairs: A New Paradigm with Novel Opportunities

Published:2024-09-11 Issue: Volume: Page:
ISSN:1178-2595
Container-title:Pharmaceutical Medicine
language:en
Short-container-title:Pharm Med

Author:

Fröling Emma^ORCID,Rajaeean Neda^ORCID,Hinrichsmeyer Klara Sonnie^ORCID,Domrös-Zoungrana Dina^ORCID,Urban Johannes Nico^ORCID,Lenz Christian

Funder

Pfizer Pharma GmbH

Publisher

Springer Science and Business Media LLC

Link

https://link.springer.com/content/pdf/10.1007/s40290-024-00536-9.pdf

Reference96 articles.

1. Evers M, Suresh B, Westra A, Zemp A. A vision for medical affairs in 2025. McKinsey & Company. 2019. https://www.mckinsey.com/industries/life-sciences/our-insights/a-vision-for-medical-affairs-in-2025. Accessed 26 June 2024.

2. Davenport T, Kalakota R. The potential for artificial intelligence in healthcare. Future Healthc J. 2019. https://doi.org/10.7861/futurehosp.6-2-94.

3. Loureiro SMC, Guerreiro J, Tussyadiah I. Artificial intelligence in business: state of the art and future research agenda. J Bus Res. 2021. https://doi.org/10.1016/j.jbusres.2020.11.001.

4. Algazy J, Garcia A, Ryan S, Westra A, Zemp A. A vision for medical affairs 2030: Five priorities for patient impact. McKinsey & Company. 2023. https://www.mckinsey.com/industries/life-sciences/our-insights/a-vision-for-medical-affairs-2030-five-priorities-for-patient-impact?cid=eml-web. Accessed 26 June 2024.

5. Shah B, Viswa CA, Zurkiya D, Leydon E, Bleys J. Generative AI in the pharmaceutical industry: Moving from hype to reality. McKinsey & Company. 2024. https://www.mckinsey.com/industries/life-sciences/our-insights/generative-ai-in-the-pharmaceutical-industry-moving-from-hype-to-reality. Accessed 26 June 2024.